Next-Generation-Sequencing Approach to Neutropenic Sepsis
Status: Recruiting
Location: See all (6) locations...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
The aim of this prospective, observational, non-interventional, multi-centre study of the diagnostic use of DISQVER in neutropenic patients with FN is to provide further evidence of the efficacy of an NGS-based approach for detecting bloodstream infection in neutropenic patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥18 years
• Informed consent
• Neutropenia defined as \<500 ANC (Absolute neutrophil Count)/µl or \<1000 WBC (White bloddcell Count)/µl if ANC is not available
• Fever (with an onset \< 24h) or Sepsis (with an onset \<24h) Patients with a life-threatening - organ dysfunction caused by a dysregulated host response to a suspected or proven infection.
Locations
Other Locations
Germany
University Hospital of Cologne
RECRUITING
Cologne
Hospital Dessau
RECRUITING
Dessau
University Hospital of Essen
RECRUITING
Essen
University Hospital of Frankfurt
RECRUITING
Frankfurt Am Main
University Hospital of Leipzig
RECRUITING
Leipzig
University Hospital of Magdeburg
RECRUITING
Magdeburg
Contact Information
Primary
Boris Böll
boris.boell@uk-koeln.de
+4922147842579
Backup
Jorge Garcia Borrega
jorge.garcia-borrega@uk-koeln.de
+4922147842579
Time Frame
Start Date: 2024-06-05
Estimated Completion Date: 2026-11-01
Participants
Target number of participants: 400
Related Therapeutic Areas
Sponsors
Collaborators: Noscendo GmbH
Leads: Boris Böll